Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) shares are going to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Down 25.3 % […]
Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) are set to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Performance NASDAQ […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 303,000 shares, a decrease of 17.6% from the November 30th total of 367,800 shares. Based on an average daily volume of 2,400,000 shares, […]
Maxim Group reissued their hold rating on shares of Processa Pharmaceuticals (NASDAQ:PCSA – Free Report) in a research note issued to investors on Friday, Benzinga reports. Processa Pharmaceuticals Stock Performance Shares of PCSA stock opened at $0.42 on Friday. The stock has a market cap of $10.46 million, a price-to-earnings ratio of -0.37 and a […]
Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report)‘s stock had its “hold” rating reissued by investment analysts at Maxim Group in a note issued to investors on Friday, Benzinga reports. Processa Pharmaceuticals Trading Up 1.0 % Shares of NASDAQ PCSA traded up $0.00 during midday trading on Friday, reaching $0.42. 476,549 shares of the company were […]